Pricing Log in Create free account

Pharming Group N.V. Sponsored ADR (PHAR) vs Savara Inc. (SVRA)

Pharming Group N.V. Sponsored ADR and Savara Inc. are both Biotechnology companies. Pharming Group N.V. Sponsored ADR and Savara Inc. are of similar size ($899.9M and $870.6M). Savara Inc. has negative trailing earnings, so its P/E is not meaningful; Pharming Group N.V. Sponsored ADR trades at 34.2×. Pharming Group N.V. Sponsored ADR has the higher net margin (6.27% vs 0.00%) and the higher return on invested capital (10.1% vs −12,213.2%). Across the 15 metrics below, Pharming Group N.V. Sponsored ADR leads on 12 and Savara Inc. on 3.

Valuation

Metric PHAR SVRA Biotechnology median
P/E 34.22 n/m 10.60
P/S 2.23 n/m 9.40
P/B 2.96 8.53 2.13
Price to free cash flow 25.00 n/m 25.18
EV/EBITDA 17.39 n/m 0.66
EV/Sales 2.00 n/m 9.02
Earnings yield 2.92% (12.01%) (32.88%)
Free cash flow yield 4.00% (9.04%) (23.13%)

Profitability

Metric PHAR SVRA Biotechnology median
Gross margin 85.10% 0.00% 68.51%
Operating margin 8.40% 0.00% 0.00%
Net margin 6.27% 0.00% 0.00%
Free cash flow margin 8.92% 0.00% 0.00%
Return on equity 8.73% (105.48%) (51.96%)
Return on assets 5.00% (78.28%) (46.06%)
Return on invested capital 10.07% (12,213.18%) 0.00%

Growth

Metric PHAR SVRA Biotechnology median
Revenue growth (TTM) 6.76% — 6.76%
EPS growth (last fiscal year) 125.00% (10.42%) 29.88%
Revenue growth, 5-year CAGR 12.13% — 9.75%
Net income growth, 5-year CAGR (40.35%) 0.00% 0.00%

Health

Metric PHAR SVRA Biotechnology median
Debt to equity 0.34 0.21 0.00
Current ratio 3.23 10.13 4.97
Net debt to EBITDA (2.21) 1.64 1.01

Dividend

Metric PHAR SVRA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric PHAR SVRA Biotechnology median
Market cap 870.59m 899.91m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack